LivaNova (LIVN) Other Operating Expenses (2015 - 2026)
LivaNova (LIVN) reported Other Operating Expenses of -$15000.0 for Q1 2026, up 97.55% on a YoY basis from -$7593.1 in Q1 2025, and up 99.12% sequentially from -$1.7 million in Q4 2025.
LivaNova (LIVN) Other Operating Expenses (2015 - 2026) Analysis & Trends
LivaNova (LIVN) has 11 years of Other Operating Expenses data on file, last reported at -$15000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Operating Expenses rose 97.55% year-over-year to -$15000.0; the trailing twelve-month figure through Mar 2026 stood at -$5.3 million (up 70.58% YoY), and the FY2025 full-year result was -$5.9 million, up 82.14% from the prior year.
- Other Operating Expenses grew to -$15000.0 in Q1 2026, from -$1.7 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $505000.0 in Q1 2022 to a low of -$23.1 million in Q3 2022.
- A 5-year average of -$6.3 million and a median of -$3.7 million in 2025 frame the typical range for Other Operating Expenses.
- Peak annual rise in Other Operating Expenses reached 105.74% in 2022, while the deepest fall reached 2068.7% in 2022.
- Tracing LIVN's Other Operating Expenses over 5 years: stood at -$5.0 million in 2022, then slumped by 73.04% to -$8.7 million in 2023, then jumped by 60.82% to -$3.4 million in 2024, then surged by 49.82% to -$1.7 million in 2025, then soared by 99.12% to -$15000.0 in 2026.
- Business Quant data shows LIVN's Other Operating Expenses at -$15000.0 in Q1 2026, -$1.7 million in Q4 2025, and -$3.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15,000.00 |
| Dec 31, 2025 | -1.71 Mn |
| Sep 30, 2025 | -3.74 Mn |
| Jun 30, 2025 | 160,000.00 |
| Mar 31, 2025 | -612,000.00 |
| Dec 31, 2024 | -3.40 Mn |
| Sep 30, 2024 | -9.18 Mn |
| Jun 30, 2024 | -4.84 Mn |
| Mar 31, 2024 | -15.62 Mn |
| Dec 31, 2023 | -8.68 Mn |
| Sep 30, 2023 | -16.01 Mn |
| Jun 30, 2023 | -10.83 Mn |
| Mar 31, 2023 | -2.31 Mn |
| Dec 31, 2022 | -5.02 Mn |
| Sep 30, 2022 | -23.14 Mn |
| Jun 30, 2022 | -1.88 Mn |
| Mar 31, 2022 | 505,000.00 |
| Dec 31, 2021 | -8.36 Mn |
| Sep 30, 2021 | -1.07 Mn |
| Jun 30, 2021 | -33.24 Mn |